Breaking News Instant updates and real-time market news.

PRTO

Proteon Therapeutics

$9.00

0.1 (1.12%)

06:25
10/19/16
10/19
06:25
10/19/16
06:25

Proteon Therapeutics initiated with an Outperform at Cowen

Cowen analyst Boris Peaker initiated Proteon Therapeutics with an Outperform saying risk/reward ahead of vonapanitase's first Phase 3 readout in December is favorable. Peaker said Phase 2 data was was better than investors currently assume with impressive rAVF results that were highly clinically meaningful.

PRTO Proteon Therapeutics
$9.00

0.1 (1.12%)

11/10/15
RAJA
11/10/15
INITIATION
Target $20
RAJA
Outperform
Proteon Therapeutics initiated with an Outperform at Raymond James
Target $20.
11/11/15
11/11/15
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Albemarle (ALB) initiated with a Neutral at UBS... Ares Management (ARES) reinstated with an Overweight at JPMorgan... Cablevision (CVC) initiated with a Neutral at SunTrust... Canadian Solar (CSIQ) initiated with an Overweight at Morgan Stanley... Carriage Services (CSV) initiated with an Outperform at Oppenheimer... Charter (CHTR) initiated with a Buy at SunTrust... Cognex (CGNX) initiated with a Market Perform at FBR Capital... Comcast (CMCSA) initiated with a Neutral at SunTrust... CubeSmart (CUBE) initiated with a Buy at BB&T... Extra Space Storage (EXR) initiated with an Underweight at BB&T... FARO Technologies (FARO) initiated with a Market Perform at FBR Capital... IPG Photonics (IPGP) initiated with an Outperform at FBR Capital... NeuroDerm (NDRM) initiated with an Outperform at Raymond James... Perceptron (PRCP) initiated with an Outperform at FBR Capital... Proteon Therapeutics (PRTO) initiated with an Outperform at Raymond James... Public Storage (PSA) initiated with an Underweight at BB&T... Pure Storage (PSTG) initiated with a Neutral at Sterne Agee CRT... Service Corp. (SCI) initiated with an Outperform at Oppenheimer... Sovran Self Storage (SSS) initiated with a Buy at BB&T... Time Warner Cable (TWC) initiated with a Neutral at SunTrust.
04/14/16
BARD
04/14/16
INITIATION
Target $20
BARD
Outperform
Proteon Therapeutics initiated with an Outperform at Baird
Target $20.
09/22/16
HCWC
09/22/16
INITIATION
Target $18
HCWC
Buy
Proteon Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth started Proteon Therapeutics with a Buy rating and $18 price target. The company's vonapanitase could become a "revolutionary treatment for dialysis patients and become a new standard of care in this multi-billion dollar market," Ramakanth tells investors in a research note.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.